New Enhancing CLIA Act: What Lab Directors Need to Know
The proposal seeks to move any future LDT authority away from the FDA
Already a member? Log in here
Essential
Subscribe today for access to
Articles and Reports
How to Stay Ahead of Anticipated CLIA Deficiencies
Consultant Nora Hess offers suggestions for clinical labs to navigate these problems
Already a member? Log in here
FDA Watch: Natera, Valar Labs Receive FDA Clearances for Bladder Cancer Tests
Natera’s assay focuses on the need for adjuvant therapy, while Valar’s test stratifies risk of recurrence
Already a member? Log in here
News-At-A-Glance: HIPAA Privacy in Emergencies
...
Already a member? Log in here
News-At-A-Glance: Another WSJ Story Implicating Laboratories
...
Already a member? Log in here
Compliance Corner
...
Already a member? Log in here
Bio-Rad Will Pay $55 Million to Settle Foreign Bribery Investigations
...
Already a member? Log in here
Preparing for the New Year: Lab Review, Audit, and Compliance Strategies
...
Already a member? Log in here
MACs Receive Instructions to Support Medical Review Decisions
...
Already a member? Log in here
HHS Seeks Help From Providers to Resolve Backlog of ALJ Appeals
...
Already a member? Log in here
CMS Establishes New ‘X’ Modifiers for Use With Modifier 59
...
Already a member? Log in here
News-At-A-Glance: New Coverage Analysis for Cervical Cancer Screening
...
Already a member? Log in here